First Horizon Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

First Horizon Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$13.6K	Buy	1,542 +971	+170%	+$8.53K	﹤0.01%	1562
2025 Q1	$4.47K	Buy	571 +211	+59%	+$1.77K	﹤0.01%	1829
2024 Q4	$3.78K	Buy	360 +253	+236%	+$3.07K	﹤0.01%	1865
2024 Q3	$1.4K	Sell	107 -62	-37%	-$944	﹤0.01%	2084
2024 Q2	$2.38K	Sell	169 -42	-20%	-$685	﹤0.01%	1937
2024 Q1	$3.56K	Buy	+211	New	+$3.14K	﹤0.01%	1892
2019 Q4	–	Sell	-31	Closed	–	–	1511
2019 Q3	$0	Hold	31	–	–	﹤0.01%	1529
2019 Q2	$0	Hold	31	–	–	﹤0.01%	1553
2019 Q1	$0	Hold	31	–	–	﹤0.01%	1557
2018 Q4	$0	Hold	31	–	–	﹤0.01%	1498
2018 Q3	$0	Hold	31	–	–	﹤0.01%	1527
2018 Q2	$0	Hold	31	–	–	﹤0.01%	1534
2018 Q1	$0	Hold	31	–	–	﹤0.01%	1425
2017 Q4	$0	Sell	31 -3	-9%	-$28	﹤0.01%	1440
2017 Q3	$0	Hold	34	–	–	﹤0.01%	1392
2017 Q2	$0	Sell	34 -1	-3%	-$10	﹤0.01%	1400
2017 Q1	$0	Buy	35 +20	+133%	+$200	﹤0.01%	1477
2016 Q4	$0	Hold	15	–	–	﹤0.01%	1435
2016 Q3	$0	Hold	15	–	–	﹤0.01%	1430
2016 Q2	$0	Hold	15	–	–	﹤0.01%	1325
2016 Q1	$0	Hold	15	–	–	﹤0.01%	1324
2015 Q4	$0	Hold	15	–	–	﹤0.01%	1258
2015 Q3	$0	Buy	+15	New	+$330	﹤0.01%	1390

Other funds holding AVDL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Horizon Advisors's AVDL Position: Q2 2025 in Review

First Horizon Advisors increased its Avadel Pharmaceuticals (AVDL) stake by 170% in Q2 2025, buying an estimated $8.53K and bringing the position to 1,542 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

First Horizon Advisors first reported a position in AVDL in Q3 2015 and has held it in 23 quarters since. 173 funds tracked by Wall St. Rank hold AVDL as of Q2 2025.

First Horizon Advisors held 1,542 shares of Avadel Pharmaceuticals worth $13.6K as of Q2 2025.
First Horizon Advisors bought 971 Avadel Pharmaceuticals shares in Q2 2025, an estimated $8.53K.
Avadel Pharmaceuticals made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1562 holding.
First Horizon Advisors first reported a position in Avadel Pharmaceuticals in Q3 2015 and has held it in 23 quarters since.
173 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.